lobbying_activities: 1948369
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1948369 | 5613f981-b99f-4f86-8054-d9946189d0f8 | Q1 | CSL BEHRING LLC | 308935 | CSL BEHRING LLC | 2017 | first_quarter | HCR | Preservation of the orphan drug tax credit due to the benefit in developing therapies for those with rare diseases. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2017-04-03T14:59:31.557000-04:00 |